Systematic Financial Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Systematic Financial Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,330	Closed	-$288K	–	468
2020 Q2	$288K	Sell	4,330 -1,455	-25%	-$97.6K	0.02%	394
2020 Q1	$354K	Sell	5,785 -730	-11%	-$54.1K	0.02%	259
2019 Q4	$573K	Sell	6,515 -660	-9%	-$55.7K	0.02%	385
2019 Q3	$541K	Sell	7,175 -1,460	-17%	-$119K	0.02%	348
2019 Q2	$738K	Sell	8,635 -3,800	-31%	-$376K	0.03%	477
2019 Q1	$1.34M	Sell	12,435 -165	-1%	-$16.4K	0.05%	312
2018 Q4	$1.07M	Buy	12,600 +825	+7%	+$79.5K	0.03%	449
2018 Q3	$1.16M	Sell	11,775 -55	-0.5%	-$5.95K	0.03%	538
2018 Q2	$1.37M	Sell	11,830 -2,215	-16%	-$243K	0.03%	431
2018 Q1	$1.39M	Buy	+14,045	New	+$1.42M	0.03%	433

Other funds holding TARO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Systematic Financial Management's TARO Position: Q3 2020 in Review

Systematic Financial Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2020, closing a stake of 4,330 shares — an estimated $288K sold.

Systematic Financial Management first reported a position in TARO in Q1 2018 and held it in 10 quarters. The position peaked at $1.39M in Q1 2018. 78 funds tracked by Wall St. Rank hold TARO as of Q3 2020.

Systematic Financial Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2020 after selling out during the quarter.
Systematic Financial Management sold 4,330 Taro Pharmaceutical Industries Ltd. shares in Q3 2020, an estimated $288K.
Systematic Financial Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2018 and held it in 10 quarters.
Systematic Financial Management's Taro Pharmaceutical Industries Ltd. position peaked at $1.39M in Q1 2018.
78 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2020.

Based on Systematic Financial Management's 13F filing for Q3 2020, filed 12 Nov 2020.